Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Fundamental Review of FTSE Small Cap Listed Stock: Aptitude Software Group PLC (APTD)

Mar 30, 2020 | Team Kalkine
Fundamental Review of FTSE Small Cap Listed Stock: Aptitude Software Group PLC (APTD)

 

Aptitude Software Group PLC

Aptitude Software Group PLC (LON: APTD) provides financial management software to over 500 million end customers. It operates with six locations around the world.  

On 30th June 2020, the group will announce its half yearly results.

Financial Highlights for the year ended on 31st December 2019 (GBP Million)

(Source: Annual Report, Company Website)

During FY19, the group revenue surged 14% to £59.7m (FY18: £52.3m) while balance sheet looked strong with cash of £33.0m (2018: £29.2m) and net funds of £30.8m (FY18: £17.3m). The software and subscription revenue represented 48% of the total revenue in FY19. The strategic milestone was disposal of Microgen Financial Systems on 28 June 2019 for cash consideration of £51.4m. Consequently, a final dividend of 3.60 pence per share was recommended in FY19 (FY18: 4.40 pence), making a total ordinary dividend of 5.40 pence per share in FY19 (FY18: 6.60 pence).

Share Price Performance
 
Daily Chart as of March 27th, 2020, after the market closed (Source: Thomson Reuters)


Aptitude Software Group’s shares closed trading session at GBX 360.00 on 27th March 2020 and was up by 6.82% versus the previous day closing price. Stock's 52 weeks High is GBX 670.00 and Low is GBX 247.00.
Valuation Methodology
 

*Peers: Kainos Group PLC, GB Group PLC, SDL PLC, Atoss Software PLC, Innofactor PLC and Proactis Holdings PLC
 
Conclusion
 
During FY19, the group has shown significant performance along with transition into new business platforms including - Aptitude Insurance Calculation Engine, Aptitude Revenue Management and the Aptitude Accounting Hub. Moreover, the Group has started FY20 with a substantial subscription sale of Aptitude Revenue Management to a North American technology enterprise.
 
However, the performance of the company in long run is subject to several risk including – technological change and its ability to adapt it with new product offering, macroeconomic fluctuations and risk pertinent to client’s confidentiality, data security and compliance with regulatory policies.
 
Due to Covid-19 crisis, the group’s business would be negatively impacted since it required frequent international travel to tap international opportunities. Such travel bans would slow down the agreements and growth in the Group’s Annual Recurring Revenue.
 
Based on the valuation and factors highlighted above, we recommend investors to keep a “Watch” on the stock at the closing price of GBX 360.00 (as on 27th March 2020), with support from new catalysts to be evaluated at a later stage.  
 
*All forecasted figures and Peers information has been taken from Thomson Reuters.


Disclaimer

PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated.
Kalkine do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…